We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Outcome of Sports Events May Depend on Circadian Rhythms

By LabMedica International staff writers
Posted on 10 Feb 2015
Print article
Image:  Graphical summary of a new study showing that athletic performance (and therefore sport event outcome) also depends on the circadian rhythms of individual athletes (Photo courtesy of University of Birmingham and Cell Press).
Image: Graphical summary of a new study showing that athletic performance (and therefore sport event outcome) also depends on the circadian rhythms of individual athletes (Photo courtesy of University of Birmingham and Cell Press).
According to a new study, the outcome of sporting events may depend on how well the timing of the match aligns with the internal biological clocks of the athletes, and so could change performance by the hour depending on what time it is for their inner clock.

The study, conducted by researchers at University of Birmingham (Birmingham, England), found that diurnal performance of competition-level athletes varied by as much as 26% over the course of the day. Those who would naturally sleep in gave their best performances hours later in the day than early birds. Athletes and coaches would do well to make note and adjust their schedules accordingly as much as possible, the researchers said.

"If a 1% difference in performance can make the difference between 1st place and 4th place in a 100 meter race and actually win you the gold medal at the Olympics, then imagine what a 26% difference in your performance could give," said principal investigator Dr. Roland Brandstaetter. There were earlier reports that suggested that athletes' personal best performances are generally in the evening. But those studies did not account for whether those athletes were of night “owl” or morning “lark” phenotypes. While an individual's circadian phenotype often does shift from childhood into adolescence and adulthood, there are real physiological differences between people based on their natural sleep/wake patterns. These differences result in disparities between their biological clocks and how they entrain to exogenous cues, such as the environmental light/dark cycle and social factors.

In this study, a novel approach was used to characterize the circadian phenotypes of more than 120 athletes. Then 20 athletes were selected representing early, intermediate, and late phenotypes and tested their cardiovascular endurance in a standard fitness test at 6 times of day.

The fitness tests revealed considerable diurnal variation in individual performance. Rather than time-of-day, the best predictor of how well those groups performed at a given hour was the amount of time elapsed since their entrained awakening (i.e., the time since they would have woken up if left to their own devices, without an alarm clock). While an early riser may be at his or her best in the early afternoon, a late riser hits his or her peak much later at night.

The researchers concluded that “determination of an athlete's personal best performance requires consideration of circadian phenotype, performance evaluation at different times of day, and analysis of performance as a function of time since entrained awakening.” This would also be relevant for non-athletic performance – "Obtaining a personal best performance is on everyone's agenda, but how to do it, now that is a different question," said co-author Elise Facer-Childs, and suggested that people would be well-advised to shift significant attention from the clock on the wall to the one that's ticking inside.

The study, by Facer-Childs E. and Brandstaetter R., was published January 29, 2015, in the Cell Press journal Current Biology.

Related Links:

University of Birmingham


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.